AU2018221048B2 - System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems - Google Patents

System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems Download PDF

Info

Publication number
AU2018221048B2
AU2018221048B2 AU2018221048A AU2018221048A AU2018221048B2 AU 2018221048 B2 AU2018221048 B2 AU 2018221048B2 AU 2018221048 A AU2018221048 A AU 2018221048A AU 2018221048 A AU2018221048 A AU 2018221048A AU 2018221048 B2 AU2018221048 B2 AU 2018221048B2
Authority
AU
Australia
Prior art keywords
insulin
basal rate
blood glucose
risk
processor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018221048A
Other languages
English (en)
Other versions
AU2018221048A1 (en
Inventor
Jonathan Hughes
Stephen D. Patek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UVA Licensing and Ventures Group
Original Assignee
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia Patent Foundation filed Critical University of Virginia Patent Foundation
Publication of AU2018221048A1 publication Critical patent/AU2018221048A1/en
Application granted granted Critical
Publication of AU2018221048B2 publication Critical patent/AU2018221048B2/en
Priority to AU2023266248A priority Critical patent/AU2023266248B2/en
Priority to AU2026202583A priority patent/AU2026202583A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Optics & Photonics (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Diabetes (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
AU2018221048A 2017-02-15 2018-02-15 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems Active AU2018221048B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2023266248A AU2023266248B2 (en) 2017-02-15 2023-11-14 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems
AU2026202583A AU2026202583A1 (en) 2017-02-15 2026-04-07 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762459100P 2017-02-15 2017-02-15
US62/459,100 2017-02-15
PCT/US2018/018414 WO2018152358A1 (en) 2017-02-15 2018-02-15 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2023266248A Division AU2023266248B2 (en) 2017-02-15 2023-11-14 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems

Publications (2)

Publication Number Publication Date
AU2018221048A1 AU2018221048A1 (en) 2019-09-05
AU2018221048B2 true AU2018221048B2 (en) 2023-10-05

Family

ID=63169641

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2018221048A Active AU2018221048B2 (en) 2017-02-15 2018-02-15 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems
AU2023266248A Active AU2023266248B2 (en) 2017-02-15 2023-11-14 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems
AU2026202583A Pending AU2026202583A1 (en) 2017-02-15 2026-04-07 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU2023266248A Active AU2023266248B2 (en) 2017-02-15 2023-11-14 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems
AU2026202583A Pending AU2026202583A1 (en) 2017-02-15 2026-04-07 System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems

Country Status (6)

Country Link
US (1) US20200046268A1 (https=)
EP (1) EP3582831A4 (https=)
JP (2) JP2020511202A (https=)
AU (3) AU2018221048B2 (https=)
CA (1) CA3053502A1 (https=)
WO (1) WO2018152358A1 (https=)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
WO2009049252A1 (en) 2007-10-10 2009-04-16 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CN111905188B (zh) 2015-02-18 2022-07-22 英赛罗公司 流体输送和输注装置及其使用方法
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
US10806859B2 (en) 2016-01-14 2020-10-20 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
CA3037432A1 (en) 2016-12-12 2018-06-21 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
EP3568860B1 (en) 2017-01-13 2025-12-10 Insulet Corporation Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP4708311A2 (en) 2017-01-13 2026-03-11 Insulet Corporation Insulin delivery methods, systems and devices
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
EP3788628B1 (en) 2018-05-04 2024-12-11 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
US11628251B2 (en) 2018-09-28 2023-04-18 Insulet Corporation Activity mode for artificial pancreas system
EP3864668A1 (en) 2018-10-11 2021-08-18 Insulet Corporation Event detection for drug delivery system
US10736037B2 (en) * 2018-12-26 2020-08-04 Tandem Diabetes Care, Inc. Methods of wireless communication in an infusion pump system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
FR3099043B1 (fr) * 2019-07-25 2023-11-03 Commissariat Energie Atomique Système automatisé de régulation de glycémie
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4070333A1 (en) * 2019-12-03 2022-10-12 Bigfoot Biomedical, Inc. Determining total daily basal dose mismatch
WO2021113859A1 (en) * 2019-12-03 2021-06-10 Bigfoot Biomedical, Inc. Determining whether adjustments of insulin therapy recommendations are being taken into account
WO2021113647A1 (en) 2019-12-06 2021-06-10 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
JP7512395B2 (ja) 2020-01-06 2024-07-08 インスレット コーポレイション 持続する残差に基づく食事および／または運動行為の予測
US12370307B2 (en) 2020-02-03 2025-07-29 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
WO2022020197A1 (en) 2020-07-22 2022-01-27 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
WO2022072332A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
EP4221588A1 (en) 2020-09-30 2023-08-09 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US20240024576A1 (en) * 2020-10-14 2024-01-25 University Of Virginia Patent Foundation Method and system of closed loop control improving glycemic response following an unannounced source of glycemic fluctuation
JP7785762B2 (ja) * 2020-12-23 2025-12-15 デックスコム・インコーポレーテッド リスクに基づく補正ボーラスを有するボーラスアドバイザ、炭水化物を含まないボーラス推奨器、及び食事承認
US20220241503A1 (en) * 2021-01-29 2022-08-04 Insulet Corporation Techniques and devices that adapt basal profiles for drug delivery applications
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
US12485274B2 (en) 2021-03-08 2025-12-02 Samsung Electronics Co., Ltd. Apparatus and method with electrical stimulus
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
EP4305636A1 (en) 2021-03-10 2024-01-17 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
EP4309188A4 (en) * 2021-03-19 2025-02-26 Horton, William B. SYSTEM AND METHOD FOR IDENTIFYING AND PREDICTING HYPOGLYCEMIC RISK
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
US12406760B2 (en) 2021-06-07 2025-09-02 Insulet Corporation Exercise safety prediction based on physiological conditions
US11792714B2 (en) * 2021-06-16 2023-10-17 Medtronic Minimed, Inc. Medicine administration in dynamic networks
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
WO2023049900A1 (en) 2021-09-27 2023-03-30 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
AU2023260398A1 (en) 2022-04-26 2024-11-21 Dexcom, Inc. System and method for titrating basal insulin doses
CN120457493A (zh) 2023-01-06 2025-08-08 英赛罗公司 自动或手动启动的随餐推注输送及随后的自动安全约束放宽
CN119215262B (zh) * 2023-06-30 2026-02-06 武汉联影智融医疗科技有限公司 针对胰岛素基础率的自动调整方法、装置和第一设备
US20250288740A1 (en) * 2024-03-18 2025-09-18 Insulet Corporation System and methods to customize modes into actionable pump settings

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120136336A1 (en) * 2007-04-25 2012-05-31 Medtronic Minimed, Inc. Closed Loop/Semi-Closed Loop Therapy Modification System
US20150025495A1 (en) * 2013-07-19 2015-01-22 Dexcom, Inc. Time averaged basal rate optimizer
WO2016133879A1 (en) * 2015-02-16 2016-08-25 University Of Virginia Patent Foundation Method, system and computer readable medium for assessing actionable glycemic risk
US20160317744A1 (en) * 2008-09-12 2016-11-03 Peter Rule Fluid component analysis system and method for glucose monitoring and control

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1728468A1 (de) * 2005-06-04 2006-12-06 Roche Diagnostics GmbH Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung
US20080269723A1 (en) * 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
EP4159114B1 (en) * 2007-10-09 2024-04-10 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
WO2009049252A1 (en) * 2007-10-10 2009-04-16 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8974439B2 (en) * 2009-01-02 2015-03-10 Asante Solutions, Inc. Infusion pump system and methods
EP2477536B1 (en) * 2009-09-14 2026-04-08 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
CN102667787A (zh) * 2009-09-30 2012-09-12 莫尔研究应用有限公司 管理胰岛素输注的监视装置
CA3298546A1 (en) * 2010-01-22 2026-03-02 Deka Products Limited Partnership Infusion pump apparatus, method and system
EP2723229B1 (en) * 2011-06-23 2018-09-26 University Of Virginia Patent Foundation Unified platform for monitoring and control of blood glucose levels in diabetic patients
US20140012511A1 (en) * 2012-07-09 2014-01-09 Dexcom, Inc. Systems and methods for leveraging smartphone features in continuous glucose monitoring
CN103418053B (zh) * 2013-07-24 2015-03-11 上海中医药大学附属龙华医院 个体化胰岛素治疗泵及其基础输注率优化方法
US10722650B2 (en) * 2014-03-28 2020-07-28 Roche Diabetes Care, Inc. System and method for adjusting therapy based on risk associated with a glucose state

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120136336A1 (en) * 2007-04-25 2012-05-31 Medtronic Minimed, Inc. Closed Loop/Semi-Closed Loop Therapy Modification System
US20160317744A1 (en) * 2008-09-12 2016-11-03 Peter Rule Fluid component analysis system and method for glucose monitoring and control
US20150025495A1 (en) * 2013-07-19 2015-01-22 Dexcom, Inc. Time averaged basal rate optimizer
WO2016133879A1 (en) * 2015-02-16 2016-08-25 University Of Virginia Patent Foundation Method, system and computer readable medium for assessing actionable glycemic risk

Also Published As

Publication number Publication date
JP2024079701A (ja) 2024-06-11
WO2018152358A1 (en) 2018-08-23
AU2018221048A1 (en) 2019-09-05
JP2020511202A (ja) 2020-04-16
CA3053502A1 (en) 2018-08-23
AU2023266248A1 (en) 2023-12-07
EP3582831A1 (en) 2019-12-25
AU2023266248B2 (en) 2026-01-08
EP3582831A4 (en) 2020-12-16
US20200046268A1 (en) 2020-02-13
AU2026202583A1 (en) 2026-04-23

Similar Documents

Publication Publication Date Title
AU2023266248B2 (en) System, method, and computer readable medium for a basal rate profile adaptation algorithm for closed-loop artificial pancreas systems
AU2018215533B2 (en) Method, system, and computer readable medium for controlling insulin delivery using retrospective virtual basal rates
US20220054748A1 (en) Control model for artificial pancreas
EP2748747B1 (en) Method, system and computer readable medium for adaptive advisory control of diabetes
US10925536B2 (en) Systems of centralized data exchange for monitoring and control of blood glucose
Schmidt et al. Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience
CN116670774B (zh) 改善未通知源血糖波动后血糖反应的闭环控制方法和系统
US11839745B2 (en) System and method for body mass index relation to patient differing psychological stress effect on blood glucose dynamics in patients with insulin dependent diabetes
Cinar Automated insulin delivery algorithms
Thabit et al. Automated insulin dosing systems: advances after a century of insulin
US20240157054A1 (en) Method and system of penalization for model predictive control in automated insulin delivery
WO2024192362A1 (en) Method for mitigating hypoglycemia rebound in an automated insulin delivery system
WO2025064417A1 (en) Method to avoid hypoglycemia by minimizing late post-prandial insulin infusion in aid system
EP4706054A2 (en) Method and system for encoding insulin dosing rules into a neural-net artificial pancreas (nap) intended for the computerized treatment of diabetes

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)